Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
Hayley Nehoff,1 Neha N Parayath,1 Laura Domanovitch,1 Sebastien Taurin,1 Khaled Greish1,2 1Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand; 2Department of Oncology, Faculty of Medicine, Suez Canal University, Egypt Abstract: The growing research interest in na...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/f9abb3210de549b4a1a58d3db4c5e591 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Hayley Nehoff,1 Neha N Parayath,1 Laura Domanovitch,1 Sebastien Taurin,1 Khaled Greish1,2 1Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand; 2Department of Oncology, Faculty of Medicine, Suez Canal University, Egypt Abstract: The growing research interest in nanomedicine for the treatment of cancer and inflammatory-related pathologies is yielding encouraging results. Unfortunately, enthusiasm is tempered by the limited specificity of the enhanced permeability and retention effect. Factors such as lack of cellular specificity, low vascular density, and early release of active agents prior to reaching their target contribute to the limitations of the enhanced permeability and retention effect. However, improved nanomedicine designs are creating opportunities to overcome these problems. In this review, we present examples of the advances made in this field and endeavor to highlight the potential of these emerging technologies to improve targeting of nanomedicine to specific pathological cells and tissues. Keywords: nanomedicine, permeability and retention effect, tissue targeting, cancer treatment, inflammation |
|---|